GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jointown Pharmaceutical Group Co Ltd (SHSE:600998) » Definitions » 3-Year EBITDA Growth Rate

Jointown Pharmaceutical Group Co (SHSE:600998) 3-Year EBITDA Growth Rate : -3.30% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Jointown Pharmaceutical Group Co 3-Year EBITDA Growth Rate?

Jointown Pharmaceutical Group Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.25.

During the past 12 months, Jointown Pharmaceutical Group Co's average EBITDA Per Share Growth Rate was 11.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -3.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 8.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 14.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Jointown Pharmaceutical Group Co was 27.30% per year. The lowest was -6.30% per year. And the median was 16.10% per year.


Competitive Comparison of Jointown Pharmaceutical Group Co's 3-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, Jointown Pharmaceutical Group Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jointown Pharmaceutical Group Co's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jointown Pharmaceutical Group Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Jointown Pharmaceutical Group Co's 3-Year EBITDA Growth Rate falls into.



Jointown Pharmaceutical Group Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Jointown Pharmaceutical Group Co  (SHSE:600998) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Jointown Pharmaceutical Group Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Jointown Pharmaceutical Group Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Jointown Pharmaceutical Group Co (SHSE:600998) Business Description

Traded in Other Exchanges
N/A
Address
No 8 Longyang Road, Hanyang District, Wuhan, CHN, 430051
Jointown Pharmaceutical Group Co Ltd is engaged in the business of wholesaling drugs and medical devices. The company offers logistics and other value-added services and primarily serves medical institutions, wholesale enterprises, and retail pharmacies.

Jointown Pharmaceutical Group Co (SHSE:600998) Headlines

No Headlines